Shop
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 26 2024
Results of a study recently published in the European Journal of Nutrition suggest that low levels of magnesium may increase the susceptibility of DNA...
The effect of a Mediterranean diet on both gastrointestinal (GI) and psychological symptoms among people with irritable bowel syndrome (IBS) was recently published in Alimentary Pharmacology & Therapeutics. Designed as a pilot study to evaluate the feasibility of the Mediterranean diet (MD) for people with IBS, this was a 6 week unblinded study in which 59 adults with Rome IV IBS, as well as mild or moderate anxiety and/or depressive symptoms, were randomized to receive either 20-30 minutes of instructions to follow an MD or instructions to continue their typical diet.
Given that very little data exists for the use of an MD among patients with IBS, this study was also designed to determine how plausible this diet would be, with no well-done randomized trials existing for an MD diet among people with IBS. Forty-eight participants completed the 6-week study, which found the MD both feasible and acceptable. Additionally, 83% of people in the MD group reported improvement in global GI symptoms and 62% reported improvement in depressive symptoms. In contrast, only 37% of people on habitual diets reported GI improvement, and only 23% reported reduced depressive symptoms. Significant reductions in the severity of symptoms, such as pain, distention, bloating, etc., were observed with the MD diet.
This MD was not a low FODMAP diet (previously shown to reduce symptoms among people with IBS), and FODMAP intake increased in participants following the MD over the 6-week study. Additionally, a microbiome analysis conducted at baseline and again at study completion did not show any significant changes between the two groups, in terms of species abundance, alpha/beta diversity, etc. Thus, while the small sample size, short duration, unclear mechanism, and lack of a high-quality control group may limit the findings, this study suggests that more robust controlled trials should be done to evaluate MD effectiveness among people with IBS.
Submit this form and you'll receive our latest news and updates.
Just published in the Mayo Clinic Proceedings is an analysis of the link between the “Mediterranean lifestyle” (comprise...
Learn moreStressors during pregnancy such as depression and obesity can lead to increased systemic inflammation and contribute to ...
Learn moreMemory and thinking tend to decline when adults enter their late 70s, but the underlying factors for this diminished cog...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment